This week, more than 40,000 oncology professionals are coming together in Chicago for one of the most important meetings in cancer research — and STAT will be there, covering the science, conversations, and key developments shaping the future of cancer care.
We're just days away from STAT@ASCO, coming up this Friday, May 30. Join us in Chicago for sharp, journalist-led conversations on the latest in cancer research and the future of cancer care. The full agenda is now live.
So many can't-miss conversations: STAT's Adam Feuerstein will speak with leaders from Gilead Sciences and Pfizer Oncology about where major drugmakers are placing their biggest oncology bets. Matthew Herper will talk with Dean Li of Merck Research Laboratories about what's next as Keytruda nears patent expiration. And Angus Chen will explore the future of the NCI and FDA with a veteran oncologist and a former FDA official.
We're almost sold out! RSVP now to join us live in Chicago.
STAT's live virtual ASCO recap is coming up Wednesday, June 4. Hear our reporters break down the biggest news and what's next from ASCO 2025.
Announcing: Special guest Susan Galbraith, executive vice president of oncology R&D at AstraZeneca, will join the conversation to share the company's latest advances in breast cancer — including pivotal data from two major ASCO presentations.
Sign up for the ASCO in 30 Seconds newsletter— your daily guide to all things ASCO, from STAT reporters on the ground in Chicago to your inbox. Get key updates each day from May 30 to June 2.
No comments